Southern Realty Trust Commits $15.0 Million to a $45.0 Million Senior Bridge Loan for the Refinancing of a Premier Retail Property in Houston, TX GlobeNewswire October 27, 2025 WEST PALM BEACH, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) — Southern Realty Trust Inc. (“SRT” or the “Company”), a lender on the Tannenbaum Capital Group (“TCG”) Real […]

Sunrise Realty Trust Commits $30.0 Million to a $45.0 Million Senior Bridge Loan to Refinance a Premier Retail Property in Houston, TX GlobeNewswire October 27, 2025 WEST PALM BEACH, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) — Sunrise Realty Trust, Inc. (“SUNS” or the “Company”) (Nasdaq: SUNS), a lender on the Tannenbaum Capital Group (“TCG”) Real

Forte Minerals Secures a Second C$5.7 Million Strategic Investment GlobeNewswire October 27, 2025 “Not for distribution to United States newswire services or for dissemination in the United States.” VANCOUVER, British Columbia, Oct. 27, 2025 (GLOBE NEWSWIRE) — Forte Minerals Corp. (“Forte” or the “Company”) (CSE: CUAU) (OTCQB: FOMNF) (Frankfurt: 2OA) is pleased to announce that

Aventis Energy Announces Filing of NI 43-101 Technical Report on the Corvo Uranium Project GlobeNewswire October 27, 2025 VANCOUVER, British Columbia, Oct. 27, 2025 (GLOBE NEWSWIRE) — Aventis Energy Inc. (“Aventis” or the “Company“) (CSE: AVE | FRA: C0O0 | OTC: VBAMF) is pleased to announce that Standard Uranium Ltd. (“Standard“) has filed a technical

Vegas Golden Knights and Richtech Robotics Partner to Help Shape the Future of Sports and Technology GlobeNewswire October 27, 2025 Collaboration Between an NHL Franchise and a Service Robotics Company Explores How AI and Automation Can Transform Fan Experiences, Hospitality, and Live Entertainment. LAS VEGAS, Oct. 27, 2025 (GLOBE NEWSWIRE) — Richtech Robotics Inc. (Nasdaq:

Amarin Issues Statement Supporting FDA's Action to Revise Labeling for Fenofibrate Drugs Reinforcing a Lack of Cardiovascular Benefit GlobeNewswire October 27, 2025 DUBLIN and BRIDGEWATER, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the science of cardiovascular care worldwide, today issued the following statement in response to

Revolution Medicines' RAS(ON) Multi-Selective Inhibitor Daraxonrasib Granted U.S. FDA Orphan Drug Designation in Pancreatic Cancer GlobeNewswire October 27, 2025 REDWOOD CITY, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that the U.S. Food and Drug Administration

Elicio Therapeutics Reports Robust T cell Responses Across Diverse HLA backgrounds in Ongoing Phase 2 AMPLIFY-7P Trial GlobeNewswire October 27, 2025 ELI-002 7P demonstrated robust mKRAS-specific T cell responses across a broad range of HLA types, highlighting its potential for use among a diverse patient population Patients treated with ELI-002 7P represented a diverse HLA

Foremost Clean Energy Appoints Seasoned Mining Executive Peter Espig to Board of Directors GlobeNewswire October 27, 2025 VANCOUVER, British Columbia, Oct. 27, 2025 (GLOBE NEWSWIRE) — Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company“), is pleased to announce the appointment of Peter Espig to its Board of Directors, effective immediately. Mr.

AlphaTON (Nasdaq:ATON) and Cyncado Therapeutics: Preclinical Mesothelioma Data Show Direct A2B Tumor Activity; TT-4 Achieved >90% Tumor Growth Inhibition; First-Patient Dosing on Track for Q1 2026 Post-conference recap highlights direct anti-tumor effects in epithelial and non-epithelioid mesothelioma models, >90% tumor growth inhibition in vivo when TT-4 was combined with anti-PD-1, and superior monotherapy activity versus